In addition to IL-17A and IL-21, a robust increase of IL-4 production in the CD4+ T cells also provides evidence that the cytokine activity from AChR-MG patients exhibits a “Th17/Tfh” signature. This evidence concerns the gene IL17A and myasthenia gravis.